Cite
HARVARD Citation
Wang, J. et al. (2018). Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD. Journal of drug targeting. pp. 643-648. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, J. et al. (2018). Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD. Journal of drug targeting. pp. 643-648. [Online].